The U.S. oncology information systems market size was exhibited at USD 840.25 million in 2023 and is projected to hit around USD 1,684.06 million by 2033, growing at a CAGR of 7.2% during the forecast period 2024 to 2033.
The growing prevalence of cancer among various demographics and rising demand for advanced innovative oncology information systems are some of the driving factors for the U.S. market. Oncology information solutions deployment is high in hospitals & cancer research institutes in the U.S. due to the rise in the prevalence of cancer and the increase in healthcare expenditure budget.
Report Coverage | Details |
Market Size in 2024 | USD 900.75 Million |
Market Size by 2033 | USD 1,684.06 Million |
Growth Rate From 2024 to 2033 | CAGR of 7.2% |
Base Year | 2023 |
Forecast Period | 2024-2033 |
Segments Covered | Products and Services, Application |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Regional Scope | U.S. |
Key Companies Profiled | Elekta AB; Accuray Incorporated; Varian Medical Systems(Siemens Healthineers); RaySearch Laboratories; Cerner Corporation (Oracle Corporation); BrainLab; Philips Healthcare; Prowess, Inc.; DOSIsoft S.A.; ViewRay Inc.; MIM Software and Flatiron |
The U.S. accounted for over 31% of the global oncology information systems market in 2023. This region has proven to be competitive and a leading market for novel cancer treatment solutions. It is considered a pioneer in adopting cancer treatment-related devices and solutions. Cancer prevalence is rising in North America, accounting for the second leading cause of death in the U.S. As per the National Cancer Institute, in January 2019, the U.S. had a cancer caseload of 16.9 million and is estimated to reach 22.2 million by 2030.
The presence of nonprofit organizations in the country is boosting R&D efforts to introduce innovative oncology information systems and solutions. Additionally, the penetration and adoption of artificial intelligence in cancer treatment software solutions are estimated to create further growth opportunities in the market. Therefore, due to the increasing adoption of oncology information systems in the region, the rising prevalence of cancers, the increasing number of players, and consistent product innovations, the market is anticipated to grow at a substantial rate during the forecast period.
The medical oncology segment accounted for the largest share (60.84%) in 2023. This modality offers a comprehensive and efficient approach to treating cancer. Furthermore, the increasing prevalence of cancer is expected to drive market growth. Increasing usage of chemotherapy, immunotherapy, targeted therapy, and hormonal therapy for effective treatment of cancer is expected to drive market growth.
The surgical oncology segment is expected to witness the highest CAGR over the forecast period. Surgery is no longer the treatment for most solid malignancies, but the combination of surgery and multi-modal therapies mostly focused on radiotherapy, targeted molecular therapies, and chemotherapy is the preferred treatment. Some of the surgical procedures such as cytoreductive surgery, isolated limb perfusion, laparoscopic cancer surgery, and sarcoma surgery can be performed in highly specialized healthcare centers. Thus, increasing complexity in surgical treatments for solid malignancies is expected to drive the growth of the surgical oncology OIS market.
The software segment accounted for the largest share of 73.25% in 2023. These software solutions facilitate the exchange of patient information across healthcare organizations to create a bridge between practitioners and radiology centers, which helps improve the safety and efficiency of cancer treatment. Companies such as Varian (Siemens Healthineers), Flatiron, and Elekta are developing innovative products by integrating solutions, including oncology-specific EMR. Hence, the software segment dominates the market as it helps streamline patient and data management processes, which can otherwise compromise data quality & participant safety.
The professional services segment is expected to witness a considerable CAGR over the forecast period. As hospitals and clinics lack the in-house resources and skills required for the deployment of OIS software, these services are outsourced. Outsourcing can be a short-term project or a long-term contract. Companies such as Varian (Siemens Healthineers), Elekta, eviCore Healthcare, and Asclepius Consulting are some of the major players providing professional services for cancer care globally.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the U.S. oncology information systems market
Products And Services
Application
Chapter 1 Research Methodology & Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased database:
1.3.1.2 internal database
1.3.2 Primary Research:
1.4 Research Scope and Assumptions
1.5 List to Data Sources
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Global Oncology Information Systems Snapshot
Chapter 3 Global Oncology Information Systems Market Variables, Trends, & Scope
3.1 Market Segmentation
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.2 Market Restraint Analysis
3.3.3 Industry Challenges
3.4 Global Oncology Information Systems Market Analysis Tools
3.4.1 Industry Analysis - Porter’s
3.4.1.1 Bargaining power of the suppliers
3.4.1.2 Bargaining power of the buyers
3.4.1.3 Threats of substitution
3.4.1.4 Threats from new entrants
3.4.1.5 Competitive rivalry
3.4.2 PESTEL Analysis
3.4.2.1 Political landscape
3.4.2.2 Economic and Social landscape
3.4.2.3 Technology landscape
3.4.2.4 Legal landscape
3.4.2.5 Technology landscape
3.5 Major Deals & Strategic Alliances Analysis
3.5.1 Joint Ventures
3.5.2 Mergers & Acquisitions
3.5.3 Licensing & Partnership
3.5.4 Technology Collaborations
3.6 Impact of COVID-19 Pandemic on Oncology Information Systems Market
Chapter 4 Oncology Information Systems Market: Product and Services Estimates & Trend Analysis
4.1 Definitions & Scope
4.2 Global Oncology Information Systems Market: Component Market Share Analysis, 2021 and 2033
4.3 Software
4.3.1 Software analysis market estimates and forecasts, 2021 - 2033
4.3.2 Patient information systems
4.3.2.1 Patient information systems analysis market estimates and forecasts, 2021 - 2033
4.3.3 Treatment planning system
4.3.3.1 Treatment planning system analysis market estimates and forecasts, 2021 - 2033
4.4 Professional services
4.4.1 Professional services analysis market estimates and forecasts, 2021 - 2033
Chapter 5 Oncology Information Systems Market: Application Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Global Oncology Information Systems Market: Application Market Share Analysis, 2021 and 2033
5.3 Medical oncology
5.3.1 Medical oncology analysis market estimates and forecasts, 2021 - 2033
5.4 Radiation oncology
5.4.1 Radiation oncology analysis market estimates and forecasts, 2021 - 2033
5.5 Surgical oncology
5.5.1 Surgical oncology analysis market estimates and forecasts, 2021 - 2033
Chapter 6. Company Profiles
6.1 Elekta AB
6.1.1 Company overview
6.1.2 Financial performance
6.1.3 Product benchmarking
6.1.4 Strategic initiatives
6.2 Varian Medical Systems
6.2.1 Company overview
6.2.2 Financial performance
6.2.3 Product benchmarking
6.2.4 Strategic initiatives
6.3 Accuray Incorporated
6.3.1 Company overview
6.3.2 Financial performance
6.3.3 Product benchmarking
6.3.4 Strategic initiatives
6.4 Cerner Corporation (Oracle Corporation)
6.4.1 Company overview
6.4.2 Financial performance
6.4.3 Product benchmarking
6.4.4 Strategic initiatives
6.5 RaySearch Laboratories
6.5.1 Company overview
6.5.2 Financial performance
6.5.3 Product benchmarking
6.5.4 Strategic initiatives
6.6 Flatiron
6.6.1 Company overview
6.6.2 Financial performance
6.6.3 Product benchmarking
6.6.4 Strategic initiatives
6.7 BrainLab
6.7.1 Company overview
6.7.2 Financial performance
6.7.3 Product benchmarking
6.7.4 Strategic initiatives
6.8 Philips Healthcare
6.8.1 Company overview
6.8.2 Financial performance
6.8.3 Product benchmarking
6.8.4 Strategic initiatives
6.9 Prowess, Inc.
6.9.1 Company overview
6.9.2 Financial performance
6.9.3 Product benchmarking
6.9.4 Strategic initiatives
6.10 DOSIsoft S.A.
6.10.1 Company overview
6.10.2 Financial performance
6.10.3 Product benchmarking
6.10.4 Strategic initiatives
6.11 ViewRay Inc.
6.11.1 Company overview
6.11.2 Financial performance
6.11.3 Product benchmarking
6.11.4 Strategic initiatives
6.12 MIM Software
6.12.1 Company overview
6.12.2 Financial performance
6.12.3 Product benchmarking
6.12.4 Strategic initiatives